Engraftment of Human Stem Cell-Derived Otic Progenitors in the Damaged Cochlea

Alejandra Lopez-Juarez1, Hanae Lahlou2, Chantal Ripoll3

  • 1CNRS UMR 7260, Aix-Marseille Université, Marseille, France; Chemical, Electronic and Biomedical Engineering, Universidad de Guanajuato, Guanajuato, Mexico.

Insights

Human otic progenitor cells (hOPCs) derived from induced pluripotent stem cells (iPSCs) successfully engrafted and survived in a guinea pig model of sensorineural deafness. These cells showed potential for sensory differentiation, offering hope for new hearing loss treatments.

Area of Science:

  • Regenerative Medicine
  • Otolaryngology
  • Stem Cell Biology

Background:

  • Sensorineural deafness often results from hair cell degeneration.
  • Stem cell therapy shows promise for organ regeneration, but cochlear engraftment remains unproven.
  • Developing effective cell-based treatments for hearing loss requires demonstrating successful cell survival and integration in the cochlea.

Purpose of the Study:

  • To generate human otic progenitor cells (hOPCs) from induced pluripotent stem cells (iPSCs).
  • To assess the in vivo survival, migration, and differentiation potential of iPSC-derived hOPCs in an adult mammalian cochlea.
  • To establish proof-of-concept for stem cell therapy in treating sensorineural deafness.

Main Methods:

  • Generated hOPCs from iPSCs in vitro, identified by otic markers.
  • Transplanted iPSC-derived hOPCs into an adult guinea pig model of ototoxicity.
  • Utilized Atoh1-GFP mouse hair cell progenitors to confirm findings in a similar delivery system.

Main Results:

  • Transplanted hOPCs successfully engrafted in non-sensory cochlear regions and survived for up to 4 weeks.
  • Engrafted hOPCs responded to cochlear environmental cues, exhibiting early sensory differentiation markers.
  • Mouse otic progenitors also migrated into damaged cochlear epithelium and adopted partial sensory cell fates.

Conclusions:

  • This study demonstrates the first successful survival and differentiation of human otic progenitor cells in an injured mature cochlear environment.
  • These findings support the potential of iPSC-derived hOPCs for cell-based therapies aimed at treating sensorineural deafness.
  • Further research into stem cell therapies is warranted to advance treatments for hearing loss.

Related Concept Videos

The Cochlea01:13

The Cochlea

The cochlea is a coiled structure in the inner ear that contains hair cells—the sensory receptors of the auditory system. Sound waves are transmitted to the cochlea by small bones attached to the eardrum called the ossicles, which vibrate the oval window that leads to the inner ear. This causes fluid in the chambers of the cochlea to move, vibrating the basilar membrane.
50.8K
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.1K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
27.3K
Adult Stem Cells01:33

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.4K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.1K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.0K